Published • loading... • Updated
Kennedy says Trump administration aims for regulated market for peptides
The proposal would ease compounding of six peptides after FDA advisers backed looser limits, despite staff opposition and limited human safety data.
- On Tuesday, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced the Trump administration aims to expand access to peptides by creating a regulated marketplace for the substances.
- Peptides have attracted consumers in a gray market for unproven uses ranging from injury recovery to beauty aids, despite the Food and Drug Administration not approving them as safe or effective.
- Outside advisers to the FDA recommended in July that the agency loosen restrictions on six of seven peptides, including BPC-157, against staff guidance and despite these substances remaining unapproved.
- The FDA submitted a proposed policy change to the White House on Thursday that could make it easier for compounding pharmacies to mix certain peptides for consumer use.
- Defending the regulatory approach on Fox News' "The Will Cain Show," Kennedy said, "Americans are going to be buying these anyway," emphasizing the need for product safety and factory inspections.
Insights by Ground AI
8 Articles
8 Articles
Kennedy says Trump administration aims for regulated market for peptides
US Health Secretary Robert F. Kennedy Jr. said on Tuesday the Trump administration aims to expand access to peptides by creating a regulated marketplace for the drugs promoted by social media influencers and by the health secretary.
·London, United Kingdom
Read Full ArticleCoverage Details
Total News Sources8
Leaning Left1Leaning Right0Center5Last UpdatedBias Distribution83% Center
Bias Distribution
- 83% of the sources are Center
83% Center
L 17%
C 83%
Factuality
To view factuality data please Upgrade to Premium
